Psychobiological Responses Following Exercise and Brain Stimulation
Virginia Commonwealth University · NCT06874595
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 29
- US sites recruiting
- 1
- Study start
- March 19, 2025
- Record last updated
- March 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Anxiety disorders are the most common mental health diagnosis in the US; 19.1% of U.S. adults (23.4% for females and 14.3% for males). In addition, the Global Burden of Disease study (2010) found that anxiety disorders were the sixth leading cause of disability (years of life lived with disability). These debilitating disorders are characterized by excessive worry and fear about everyday situations, and physical symptoms including restlessness, being easily fatigued, difficulty concentrating, irritability, muscle tension, or sleep disturbance. Furthermore, anxiety is linked to other mental disorders including depression and substance abuse; is associated with cardiovascular disease risk factors and a higher rate of cardiovascular disease; and is related to premature mortality. These data have led to the investigation of a breadth of plausible treatments for anxiety, including medications and psychotherapy. However, likely due to the breadth of complex mechanisms involved in the pathophysiology of anxiety disorders and the unfavorable side effects of various medications, a considerable number of individuals do not have a satisfactory response to these treatments. This has led investigators to examine plausible novel interventions to alleviate anxiety and its symptoms.
Being studied: Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS); Cycling exercise at 65% of HRR exercise followed by sham HD-tDCS (exercise + sham tDCS); No exercise followed by HD-tDCS (no exercise + HD-tDCS).; State Anxiety Inventory; Visual Analog Scale for Anxiety
Conditions: Psychological
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy adults
- aged 18 to 50
- consent and complete a Physical Activity Readiness Questionnaire (PAR-Q)
- be free from any neurological or psychiatric disorder
- not be taking any medication that could affect the central nervous system
- not have any contraindication for HD-tDCS (i.e. not having metal implanted in the head, pacemaker, medical bumps, seizures, lesions on the scalp or head ) or for bioelectrical impedance (i.e., electronic medical implant, such as a pacemaker or implantable cardioverter defibrillator, and limb amputation)
- not be regular users of tobacco products (cigarettes, cigars, chewing tobacco)
- not consume an average of more than ten alcoholic beverages per week
Exclusion Criteria
- Individuals who do not meet the PAR-Q screening criteria for participation in moderate physical activity will be excluded from participating in this study
- women who are pregnant will be exclude from this study
Recruiting US locations
Virginia Commonwealth University
Richmond, VA 23298
Site contact: Edmund Acevedo, PhD · 804-828-1948 · eoacevedo@vcu.edu
Study contacts (from the official record)
- Edmund Acevedo · (804) 814-4355 · eoacevedo@vcu.edu
- Monique Morton · 804-828-1948 · mortonmy@vcu.edu
Similar studies in Virginia
All healthy volunteers studies in Virginia →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Charlottesville, VA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Charlottesville, VA + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Richmond, VA + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
HTIC, Inc
- Location
- Richmond, VA
- Eligibility basics
- Ages 18–65